PMID: 6610841Jul 1, 1984Paper

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Neurology
G McKhannE M Stadlan

Abstract

Clinical criteria for the diagnosis of Alzheimer's disease include insidious onset and progressive impairment of memory and other cognitive functions. There are no motor, sensory, or coordination deficits early in the disease. The diagnosis cannot be determined by laboratory tests. These tests are important primarily in identifying other possible causes of dementia that must be excluded before the diagnosis of Alzheimer's disease may be made with confidence. Neuropsychological tests provide confirmatory evidence of the diagnosis of dementia and help to assess the course and response to therapy. The criteria proposed are intended to serve as a guide for the diagnosis of probable, possible, and definite Alzheimer's disease; these criteria will be revised as more definitive information become available.

Citations

Jun 9, 2000·Statistics in Medicine·S L Hui, S Gao
Apr 20, 1999·Genetic Epidemiology·H VézinaD Gauvreau
Jul 22, 1999·Genetic Epidemiology·R Heun
Jul 22, 1998·Journal of Clinical Laboratory Analysis·K Ghanbari, H A Ghanbari
Oct 17, 1998·Journal of Clinical Laboratory Analysis·H GhanbariP Averback
Mar 21, 2000·Depression and Anxiety·R L OwnbyR Duara
Sep 26, 2000·Microscopy Research and Technique·F EustacheJ C Baron
Jul 1, 1991·Journal of Clinical Psychology·W MittenbergR Levitt
Mar 1, 1994·Journal of Clinical Psychology·M MitrushinaA Chervinsky
Jul 1, 1994·Journal of Clinical Psychology·M MitrushinaA Chervinsky
Jul 21, 2000·Health Economics·C K AndersenP Kragh-Sørensen
Jan 23, 1999·Annals of Neurology·W J HoogendijkD F Swaab
Sep 11, 1999·Annals of Neurology·R MayeuxP D Mehta
Oct 8, 1999·Annals of Neurology·M DahiyatD St Clair
Oct 12, 2000·Annals of Neurology·S HiguchiH Arai
Mar 26, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·R J CaselliJ E Parisi
Apr 7, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·R J Elble, K Leffler
Feb 4, 2005·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Lynnette J CookDavid C Rubinsztein
Sep 25, 2004·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Dimitrios AvramopoulosSusan S Bassett
Sep 25, 2004·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Ellen M WijsmanGerard D Schellenberg
Jul 12, 2002·Annals of Neurology·Wiesje M van der FlierHuub A M Middelkoop
Sep 5, 2002·Annals of Neurology·Reinhold SchmidtLenore J Launer
Sep 5, 2002·Annals of Neurology·Thomas J MontineJason D Morrow
Sep 3, 2002·Annals of Neurology·Demetrios J SahlasSandra E Black
Jan 2, 2003·Annals of Neurology·Florinda FerreriPaolo Maria Rossini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.